Malar Rash: Causes, Sun Triggers, and Lupus Diagnosis

A malar rash is a red or discolored eruption that spreads symmetrically across both cheeks and the bridge of the nose, forming a shape resembling a butterfly’s open wings. It is most closely associated with systemic lupus erythematosus (SLE), where it appears in roughly half of all patients at some point during their disease. The rash is flat or slightly raised, characteristically spares the creases running from the nose to the corners of the mouth, and often worsens after sun exposure. While it is one of the most recognizable signs in medicine, it is also one of the most commonly confused with other conditions.

What It Looks Like and Why the Shape Matters

The classic malar rash is a fixed area of redness stretching continuously from one cheek, across the nasal bridge, to the other cheek. It can be flat or mildly elevated, and it sometimes has a faint scale, but it does not produce bumps, pus-filled spots, or visible broken blood vessels. That last point matters a great deal for diagnosis. A case report in QJM described the rash as a “fixed erythematous maculopapular rash with hyperpigmentation over the cheeks and nasal bridge sparing nasolabial fold,” and noted that malar rash appears in an estimated 46 to 65 percent of lupus patients.1QJM: An International Journal of Medicine. Butterfly rash: hallmark of lupus

The nasolabial fold sparing is one of the single most useful clues. The nasolabial folds are the creases that run from the sides of your nose down to the corners of your mouth. In a lupus malar rash, these folds stay clear while the surrounding skin flares. This happens because the rash is driven largely by ultraviolet light exposure, and those deeper skin folds are relatively shielded from direct sunlight. The sparing pattern helps distinguish a malar rash from conditions like dermatomyositis, which typically does involve the nasolabial folds.2QJM: An International Journal of Medicine. Butterfly rash: hallmark of lupus

A review in Rheumatology emphasized that a true malar rash is “entirely flat without papules or pustules and does not lead to teleangiectasias,” and that its butterfly shape has become so iconic it serves as the symbol for most lupus patient associations worldwide.3Rheumatology. Classifying and diagnosing systemic lupus erythematosus in the 21st century

Why Sunlight Triggers the Rash

Photosensitivity is one of the defining features of lupus skin disease, and it is a major reason the malar rash sits where it does: the cheeks and nose are among the most sun-exposed surfaces on the body. But the relationship between UV light and lupus skin goes far deeper than a simple sunburn.

Research into the mechanisms behind lupus photosensitivity has identified several overlapping pathways. UV radiation can trigger cell death in skin cells, and the debris from those dying cells includes fragments that the immune system in lupus patients mistakenly targets as foreign. UV exposure also ramps up adhesion molecules and inflammatory signaling chemicals in the skin, essentially putting out a welcome mat for immune cells to flood the area. On top of that, UV light can push certain self-targeting antibodies toward the skin surface and induce enzymes that generate nitric oxide, further fueling inflammation.4PubMed. Photosensitivity in lupus erythematosus

A 2025 review in Nature Reviews Rheumatology highlighted that both visually normal and already-affected lupus skin shows early and persistent activation of type I interferons, a family of immune signaling molecules. These interferons drive photosensitivity, recruit inflammatory cells into the skin, and amplify the inflammatory response in both immune cells and the skin’s own structural cells.5PubMed Central. Cutaneous lupus erythematosus – from pathogenesis to targeted therapy This means that in a person with lupus, even skin that looks perfectly normal is primed to overreact to sunlight. A day at the beach or even incidental sun exposure through a car window can trigger a flare.

The Rosacea Problem

Rosacea is by far the most common condition mistaken for a lupus malar rash. Both produce facial redness centered on the cheeks and nose. Both can worsen with sun exposure. And both are common enough that a doctor seeing a flushed face has to weigh the two seriously. But the differences, once you know what to look for, are real.

A lupus malar rash is flat, spans the nose bridge continuously, and spares the nasolabial folds. Rosacea, on the other hand, tends to produce visible blood vessels (telangiectasias), small bumps or pimples, and does not spare the folds. Rosacea is also associated with skin mites called Demodex and enlarged oil glands, features absent in lupus skin.6PubMed. Comparative analysis of rosacea and cutaneous lupus erythematosus: histopathologic features, T-cell subsets, and plasmacytoid dendritic cells

When the two conditions are examined under a dermoscope (a specialized magnifying tool used on skin), they show strikingly different patterns. In a study comparing lupus malar rash to a subtype of rosacea, the lupus rash showed reddish or salmon-colored follicular dots surrounded by white halos, a pattern researchers called the “inverse strawberry” sign. This was present in about half of lupus cases and was highly specific. Rosacea, by contrast, showed network-like vessel patterns called vascular polygons in over 90 percent of cases.7PubMed. Dermoscopy in the differential diagnosis between malar rash of systemic lupus erythematosus and erythematotelangiectatic rosacea: an observational study

When a skin biopsy is performed, the distinction becomes even clearer. Lupus skin shows damage at the junction between the outer and inner layers of skin (interface dermatitis), with the immune system attacking the base of the outer skin layer. There is also thickening of the basement membrane and deposits of a gel-like substance called mucin. Rosacea biopsies instead show inflammation centered around blood vessels and hair follicles, along with Demodex mites.8PubMed Central. LC-OCT for Cutaneous Lupus Erythematosus: Characterization Across Disease Subtypes and Differentiation From Rosacea A review of histological features found that lupus skin had significantly more of a particular type of immune cell called plasmacytoid dendritic cells, which clustered together in a pattern not seen in rosacea.9PubMed. Comparative analysis of rosacea and cutaneous lupus erythematosus: histopathologic features, T-cell subsets, and plasmacytoid dendritic cells

The practical lesson here: if you have persistent facial redness and have been told it is rosacea but standard rosacea treatments are not working, or if the redness spans the bridge of your nose and spares the creases beside your nostrils, it is worth asking your doctor whether lupus should be investigated.

How Malar Rash Fits Into a Lupus Diagnosis

A malar rash alone does not confirm lupus. Lupus is diagnosed through a combination of clinical features, lab results, and sometimes biopsy findings. But the rash carries significant weight in the classification systems doctors use.

Under the 2019 EULAR/ACR classification criteria, which represent the current international standard, acute cutaneous lupus (the category that includes malar rash) earns 6 points toward the 10-point threshold needed for classification as SLE.10PubMed Central. 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus That is a large chunk of the required total, reflecting how specific the rash is for lupus. Before these criteria can even be applied, a patient must first test positive for antinuclear antibodies (ANA), a screening blood test.

Not every lupus patient gets a malar rash. One study of a Colombian lupus population found that malar rash was documented in about 14 percent of cases when applying one set of classification criteria.11Journal of Translational Autoimmunity. Comparison of the sensitivity of the EULAR / ACR 2019 and SLICC 2012 classification criteria in a Colombian population with systemic lupus erythematosus Other estimates, as noted earlier, put the figure between 46 and 65 percent. The variation depends partly on the population studied and partly on how strictly the rash is defined. Photographs are increasingly used to verify that what a clinician calls a malar rash truly meets the description, since lookalike conditions muddy the picture.

Recognizing Malar Rash in Darker Skin

Most textbook images of a malar rash show it on light skin, where the red-pink butterfly pattern stands out vividly. In people with darker skin tones, the rash can look very different. Instead of bright redness, the rash may appear as a subtle darkening, a violet or brown discoloration, or a barely perceptible change in skin texture. This makes it much harder to spot, both for patients and for clinicians who were trained primarily on images of lighter skin.

A review in Dermatologic Clinics noted that erythema in darker skin types is difficult to detect, particularly in people with very deep skin tones.12Dermatologic Clinics. Diagnosing Disorders of Facial Erythema This matters because delayed recognition of a malar rash can delay the lupus diagnosis itself, and lupus diagnosed late tends to have worse outcomes. If you have darker skin and notice a persistent change in color or texture across your cheeks and nose, especially if it worsens with sun exposure or comes alongside joint pain and fatigue, bring it up with your doctor. Do not wait for it to look like the textbook photo.

Malar Rash in Children

Lupus can and does occur in children and teenagers, and when it does, the malar rash is often among the earliest signs. In a study of Filipino children and adolescents with lupus, fever and malar rash were the most common features at disease onset, with fever present in about half and malar rash in roughly 41 percent at the time symptoms first appeared. By the time of formal diagnosis, malar rash had been documented in about 65 percent of cases.13PubMed Central. Clinical presentations and outcomes of Filipino juvenile systemic lupus erythematosus

Childhood-onset lupus tends to be more aggressive than the adult form, with higher rates of kidney involvement and more active disease overall. The malar rash in children can be particularly distressing because it is visible, hard to hide, and arrives during a developmental period when appearance and peer acceptance carry enormous emotional weight.

Does a Malar Rash Predict Kidney Problems?

This is one of the more anxiety-provoking questions for people newly diagnosed with lupus. Kidney involvement, called lupus nephritis, is one of the most serious complications of SLE, and some research has examined whether the presence of a malar rash signals higher risk.

A large Korean study compared lupus patients with and without kidney disease and found that malar rash was more common in the group with kidney involvement: about 49 percent of those with lupus nephritis had a malar rash, compared with about 39 percent of those without it. In a preliminary analysis, the presence of a malar rash was associated with roughly 1.5 times the odds of having lupus nephritis.14Journal of Rheumatic Diseases. Clinical and Genetic Risk Factors Associated With the Presence of Lupus Nephritis However, when the researchers adjusted for other risk factors like age, sex, antibody profiles, and genetic risk scores, the malar rash itself was no longer an independent predictor. The factors that remained most strongly linked to kidney disease were younger age at diagnosis, certain antibody types (anti-dsDNA and anti-Sm), low complement levels, and inflammation of the heart or lung linings.15Journal of Rheumatic Diseases. Clinical and Genetic Risk Factors Associated With the Presence of Lupus Nephritis

So while a malar rash tends to appear alongside more active disease overall, it does not independently doom someone to kidney complications. The antibody and complement findings in blood work are more informative for predicting that risk.

Treatment and Sun Protection

Managing a malar rash starts with aggressive sun protection. That means broad-spectrum sunscreen (reapplied frequently), wide-brimmed hats, lightweight long-sleeved clothing, and avoiding peak sun hours whenever possible.16PubMed. Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations This is not optional cosmetic advice. Because UV light is a direct trigger for the inflammatory cascade in lupus skin, sun protection is genuinely therapeutic.

For the rash itself, topical corticosteroids are usually the first-line treatment, applied directly to the affected skin to dampen inflammation. When topical treatment is not enough, the antimalarial drug hydroxychloroquine is the standard systemic therapy. It works well for many patients, reducing both skin and joint symptoms. For cases that do not respond to hydroxychloroquine alone, adding a second antimalarial called quinacrine has shown benefit. In a study of patients with various forms of lupus skin disease, including six cases of acute malar rash, the combination of hydroxychloroquine and quinacrine led to significant improvement.17PubMed. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine

Some cases remain stubbornly resistant to standard treatment. A case report described a patient whose malar rash persisted despite hydroxychloroquine therapy and significantly affected her quality of life, prompting exploration of experimental approaches.18PubMed Central. Adjunctive molecular hydrogen therapy for refractory malar rash in systemic lupus erythematosus: A case report with immunological insights Newer biologic therapies targeting specific immune pathways, including the interferon system described earlier, are under active investigation for cutaneous lupus that does not respond to conventional drugs.

The Emotional Toll of a Visible Rash

Lupus is often called an invisible illness because many of its symptoms, like fatigue, joint pain, and organ inflammation, cannot be seen. The malar rash is the glaring exception. It sits in the center of the face, impossible to conceal without makeup, and can flare unpredictably. The psychological burden this creates is real and measurable.

Research on quality of life in cutaneous lupus found that patients with lupus skin disease had worse quality of life than people with acne, non-melanoma skin cancer, or hair loss. When it came to mental health specifically, their scores were comparable to or worse than those of patients with high blood pressure, type 2 diabetes, recent heart attacks, or heart failure. Factors that predicted the worst quality of life included female sex, widespread disease, severe disease, the location of lesions, and younger age.19PubMed Central. Quality of Life in Cutaneous Lupus Erythematosus

A separate study using a validated model found that body image dissatisfaction was by far the strongest predictor of overall quality of life in cutaneous lupus, outweighing disease activity, pain, and fatigue.20PubMed Central. Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model In practical terms, how people felt about their appearance mattered more to their daily well-being than how active their disease was.

This has led to growing interest in supportive interventions beyond medication. A controlled study of women with lupus and permanent skin damage found that learning to use cosmetic camouflage (specialized concealing makeup) led to measurable improvements in quality of life, mood, self-image, and physical functioning. Depression and anxiety scores improved, and self-esteem increased.21PubMed. Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study Cosmetic camouflage is not a medical treatment, but it addresses a real and under-recognized source of suffering. If your dermatologist or rheumatologist has not mentioned it, it is worth asking about.

Where the Name Comes From

The word “lupus” has a surprisingly tangled history. It comes from the Latin for “wolf” and was first applied to skin disease around the ninth century, originally describing ulcerative lesions said to resemble a wolf’s bite.22BMJ. The history of lupus throughout the ages For centuries the term was used loosely for various destructive skin conditions, including what we now know as skin tuberculosis, and the distinction between lupus vulgaris (tubercular) and cutaneous lupus in its modern sense was not clearly drawn until the 1930s.

The butterfly rash itself entered the medical vocabulary through a series of European dermatologists. The first clear description of lupus erythematosus came from the French physician Biett in the early 1800s, reported by his student Cazenave under the name “erythema centrifugum” in 1833. Cazenave later coined the term “lupus érythémateux” in 1850. In 1846, the Viennese dermatologist Hebra described the disc-shaped patches of the disease and introduced the butterfly comparison for the malar rash, a metaphor that has stuck for nearly two centuries.23Rheumatic Disease Clinics of North America. The History of Lupus Erythematosus: From Hippocrates to Osler The image proved so vivid that it became the organizing symbol of the disease, adopted by patient advocacy groups worldwide long before the autoimmune mechanisms behind the rash were understood.